Clinical Trial Eligibility Criteria Fulfill
Item
to be included in this study, you must meet the following criteria:
boolean
C1516637 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Carcinoma of unknown primary origin
Item
histologically confirmed carcinoma of unknown primary site
boolean
C0220647 (UMLS CUI [1])
Chemotherapy Regimen | Progressive Disease
Item
progressive disease after treatment with one previous chemotherapy regimen.
boolean
C0392920 (UMLS CUI [1])
C1335499 (UMLS CUI [2])
Immunotherapy | Biological Response Modifier Therapy
Item
treatment with one previous immunotherapy or biotherapy regimen.
boolean
C0021083 (UMLS CUI [1])
C0005527 (UMLS CUI [2])
oxaliplatin | capecitabine | Fluorouracil
Item
no previous treatment with oxaliplatin, capecitabine, or 5-fu.
boolean
C0069717 (UMLS CUI [1])
C0671970 (UMLS CUI [2])
C0016360 (UMLS CUI [3])
Platinum-based Drug
Item
previous treatment with other platinum agents
boolean
C2266918 (UMLS CUI [1])
Measurable Disease | Evaluable Disease
Item
patients must have measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
ECOG performance status
Item
ecog performance status more than 2
boolean
C1520224 (UMLS CUI [1])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, liver and kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Informed Consent
Item
understand the nature of this study and give written informed consent.
boolean
C0021430 (UMLS CUI [1])
Clinical Trial Eligibility Criteria Fulfill
Item
you cannot participate in this study if any of the following apply to you:
boolean
C1516637 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Age
Item
age < 18 years
boolean
C0001779 (UMLS CUI [1])
Therapeutic procedure Invasive cancer
Item
history of treatment of any invasive malignancy within the last 5 years
boolean
C0087111 (UMLS CUI [1,1])
C0677898 (UMLS CUI [1,2])
Comorbidity
Item
coexistent medical illnesses
boolean
C0009488 (UMLS CUI [1])
Heart Disease Clinical Significance
Item
clinically significant cardiac disease
boolean
C0018799 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
Peripheral Neuropathy | CTCAE Grades
Item
preexisting peripheral neuropathy > grade 1
boolean
C0031117 (UMLS CUI [1])
C1516728 (UMLS CUI [2])
Upper Gastrointestinal Tract Integrity Physical Lacking
Item
lack of physical integrity of the upper gastrointestinal tract
boolean
C3203348 (UMLS CUI [1,1])
C0205266 (UMLS CUI [1,2])
C0205485 (UMLS CUI [1,3])
C0332268 (UMLS CUI [1,4])
Blood Coagulation Disorder Uncontrolled
Item
pre-existing uncontrolled coagulopathy
boolean
C0005779 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
women who are pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Clinical Trial Eligibility Criteria Additional
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])